Suppr超能文献

评估 GERAADA 评分对急性 A 型主动脉夹层患者 30 天死亡率的预测价值。

Evaluation of the GERAADA score for prediction of 30-day mortality in patients with acute type A aortic dissection.

机构信息

Department of Cardiothoracic Surgery, Heart Center, University of Cologne, Cologne, Germany.

Department of Political Science & Economics, Rowan University, Glassboro, NJ, USA.

出版信息

Eur J Cardiothorac Surg. 2021 May 8;59(5):1109-1114. doi: 10.1093/ejcts/ezaa455.

Abstract

OBJECTIVES

The German Registry of Acute Aortic Dissection Type A (GERAADA) score to predict 30-day mortality in patients suffering from acute aortic dissection type A (AADA) was recently introduced. The aim of this study was to evaluate if the GERAADA score's prediction corresponds with the authors' institutional results.

METHODS

All consecutive AADA patients between 2010 and 2020 were included. Retrospective data collection comprised 11 preoperative parameters: age, sex, previous cardiac surgery, inotropic support at referral, resuscitation before surgery, aortic regurgitation, preoperative hemiparesis, intubation/ventilation at referral, preoperative organ malperfusion, extension of aortic dissection and location of primary entry site. Calculations of the GERAADA score were individually performed by a cardiac surgeon blinded to the study for all patients via a web-based application (https://www.dgthg.de/de/GERAADA_Score).

RESULTS

A total of 371 AADA patients were operated at the authors' institution. The mean age was 62.7 ± 13.5 years and 233 (63%) were males. Prediction of 30-day mortality was accurate for the entire study cohort (actual vs predicted 30-day mortality: 15.1% vs 15.7%; P = 0.776) as well as for all 26 subgroups. In addition, preoperative resuscitation (P < 0.001), advanced age (P = 0.042) and other/unknown malperfusion (P = 0.032) were identified as independent risk factors.

CONCLUSIONS

The GERAADA score prediction of 30-day mortality after surgery is accurate, easily accessible due to its web-based platform and can be calculated with very basic preoperative clinical parameters. A prospective clinical trial is required to further evaluate the new GERAADA score as a useful tool to allow for improved decision-making in the emergency setting of AADA.

摘要

目的

最近引入了一种用于预测急性主动脉夹层 A 型(AADA)患者 30 天死亡率的德国急性主动脉夹层 A 型登记处(GERAADA)评分。本研究的目的是评估 GERAADA 评分的预测是否与作者机构的结果相符。

方法

纳入 2010 年至 2020 年期间连续的所有 AADA 患者。回顾性数据收集包括 11 项术前参数:年龄、性别、既往心脏手术、转诊时的正性肌力支持、手术前的复苏、主动脉瓣反流、术前偏瘫、转诊时的插管/通气、术前器官灌注不良、主动脉夹层的扩展和原发入口部位。所有患者的 GERAADA 评分均由一名心脏外科医生通过一个基于网络的应用程序(https://www.dgthg.de/de/GERAADA_Score)进行单独计算,该医生对研究结果不知情。

结果

作者机构共对 371 例 AADA 患者进行了手术。平均年龄为 62.7±13.5 岁,男性 233 例(63%)。整个研究队列的 30 天死亡率预测准确(实际与预测的 30 天死亡率:15.1%比 15.7%;P=0.776),所有 26 个亚组的预测均准确。此外,术前复苏(P<0.001)、高龄(P=0.042)和其他/未知灌注不良(P=0.032)被确定为独立的危险因素。

结论

基于网络平台,GERAADA 评分易于获得,且其术后 30 天死亡率预测准确,可使用非常基本的术前临床参数进行计算。需要进行前瞻性临床试验来进一步评估新的 GERAADA 评分作为一种有用的工具,以提高 AADA 紧急情况下的决策能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验